Asian Spectator

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

Magazine

4 gejala ini bisa bantu deteksi kanker ovarium lebih dini

Sebuah pendekatan diagnosis baru bisa bantu mendeteksi lebih dini keberadaan kanker ovarium.Ground Picture/ShutterstockKanker ovarium atau indung telur sering kali terdiagnosis ketika sudah stadium la...

Jokowi gagal penuhi hak lingkungan warga—bagaimana risikonya di era Prabowo?

Prabowo-Gibran yang pencalonannya sebagai Presiden dan Wakil Presiden memantik kontroversi akan bekerja mulai 20 Oktober 2024.Untuk mengawal pemerintahan mereka, kami menerbitkan edisi khusus #PantauP...

Persaingan global keras, mampukah Prabowo-Gibran capai pertumbuhan ekonomi 8%?

Prabowo-Gibran yang pencalonannya sebagai Presiden dan Wakil Presiden memantik kontroversi akan bekerja mulai 20 Oktober 2024.Untuk mengawal pemerintahan mereka, kami menerbitkan edisi khusus #PantauP...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion